TNF and Hepatic fibrosis: The higher NIC dose resulted in even more significant reductions in TNF-α and iNOS protein expression and NF-κB-p65 gene expression, with reductions of approximately 50%, 65%, and 50%, respectively, relative to the TAA-induced liver fibrosis group.